There is now some evidence that major depression is accompanied by activation of the inflammatory response
There is some new evidence that major depression is accompanied by activation of the inflammatory response system (IRS). The evidence includes the following: (1) increased numbers of peripheral blood mononuclear cells (PBMC), such as neutrophils, monocytes, and activated T lymphocytes (Herbert and Cohen 1993; Maes et al. 1992 Maes et al. , 1993c Muller et al. 1993; Sluzewska et al. 1996a Sluzewska et al. , 1996b Seidel et al. 1996b; Perini et al. 1995) ; (2) increased secretion of neopterin, a sensitive marker of cell-mediated immunity (Duch et al. 1984; Dunbar et al. 1992; Maes et al. 1994; Bonaccorso et al. 1997) ; (3) increased secretion of prostaglandin E2 (PGE2) in serum, CSF or culture supernatant obtained after polyclonal stimulation of whole blood (Linnoila et al. 1983; Calabrese et al. 1986; Song et al. submitted; and (4) the presence of a moderate acute phase response, as indicated by increased serum concentrations of positive acute phase reactants, such as haptoglobin, C-reactive protein, and ␣ 1-antitrypsin (Maes et al. 1993b (Maes et al. , 1995b (Maes et al. , 1997a Joyce et al. 1992; Sluzewska et al. 1996a ) and decreased serum concentrations of negative acute phase reactants, such as albumin, transferrin, and zinc (Swartz 1990; Maes 1997; McLoughlin and Hodge 1990; Maes et al. 1997b ). Activation of the IRS has also been observed in the olfactory bulbectomized and the mild stress rat model of depression Sluzewska et al. 1994) .
It is thought that an increased production of proinflammatory cytokines, such as interleukin-1 ␤ (IL-1 ␤ ), IL-2, IL-6 or interferon-␥ (IFN ␥ ) may be orchestrating the activation of the IRS in depression (Maes 1997) . There is some evidence for increased (1) production of pro-inflammatory cytokines such as IL-1 ␤ , IL-6 and IFN ␥ in culture supernatant of mitogen-stimulated PBMC; and (2) serum concentrations of IL-6, IL-2, and IL-2 receptor in depression (Nassberger and TraskmanBendz 1993; Maes et al. 1993a Maes et al. , 1993b Maes et al. , 1994 Sluzewska et al. 1995a Sluzewska et al. , 1995b Sluzewska et al. , 1996a Sluzewska et al. , 1996b Seidel et al. 1995 Seidel et al. , 1996a Frommberger et al. 1997) . The above cytokines are known to orchestrate the key steps in the complex network, which regulates responses in cell-mediated and humoral immunity and in the IRS (Cavaillon 1996) . Major advances in the understanding of the modulation of cell-mediated immunity and the IRS were the identification of (1) two mutually exclusive populations of T helper (Th) cells (i.e., Th1, which produce IFN ␥ and IL-2, and Th2, which produce IL-4 and IL-5); and (2) negative immunoregulatory cytokines (i.e., IL-10, which potently suppresses Th1-like effector functions, such as the production of proinflammatory cytokines) (Cavaillon 1996) .
It has been suggested that increased production of pro-inflammatory cytokines may play a role in the etiology of depression (Smith 1991; Maes 1997; Yirmiya 1996 Yirmiya , 1997 . Indeed, IL-1, IL-2, and IFNs given to experimental animals and humans may produce behavioral alterations and symptoms similar to those observed in major depression, such as anhedonia, anorexia, weight loss, social withdrawal, psychomotor retardation, anergy, irritability, sleep disturbances, and malaise (Smith 1991; Yirmiya 1996 Yirmiya , 1997 Bluthé et al. 1992; McDonald et al. 1987) . If increased production of pro-inflammatory cytokines is at all involved in the etiology of depression one would expect that antidepressive treatments have negative immunoregulatory effects. Recently, Xia et al. (1996) showed clomipramine, imipramine, and citalopram significantly suppressed the secretion of IL-2 by stimulated T lymphocytes and of IL-1 ␤ and TNF ␣ by stimulated monocytes. Moreover, there was a trend toward a significant decreased secretion of IFN ␥ by stimulated T lymphocytes preincubated with the above antidepressants (Xia et al. 1996) . Recently, it has been shown that diluted whole blood stimulated with phytohemagglutinin (PHA) ϩ lipopolysaccharide (LPS) offers the most appropriate and reproducible culture condition in order to measure cytokines, such as IFN ␥ , IL-6, and IL-1 (review: De Groote et al. 1992, 1993; Zangerle et al. 1992) . Diluted whole blood cultures reflect the in vivo immune cellular and humor interactions and may be employed to examine the effects of any substances or drugs on cytokine secretion . The ratio of IFN ␥ production/IL-10 production in culture supernatant is of critical importance in determining the capacity of supernatants to activate or inhibit monocytic and T lymphocytic functions (Katsikis et al. 1995) .
The aims of the present study were to examine the effects of the tricyclic antidepressant, clomipramine, the selective serotonin reuptake inhibitor (SSRI), sertraline, and the heterocyclic antidepressant, trazodone, on the production of IFN ␥ and IL-10 (and their ratio) by diluted whole blood stimulated with PHA ϩ LPS.
SUBJECTS AND METHODS
Blood samples for the determination of cytokine secretion were collected from nine healthy volunteers (mean age ϭ 33.1 Ϯ 7.5 years; male/female ratio: 5/4). All subjects gave informed consent after the study design was fully explained. Exclusion criteria for subjects were the following: (1) subjects with a past or present history of psychiatric disorder (axis-1 and axis-2); (2) subjects who ever had been taking major psychotropic medications, such as antidepressants, antipsychotics; (3) subjects with drug (alcohol and any other drug of dependence) abuse; (4) smokers; (5) subjects with any medical (e.g., endocrine, immune, metabolic) disorders, such as diabetes, autoimmune disorders, inflammatory bowel disease, acquired immunodeficiency syndrome; and (6) subjects who currently (2 weeks prior to the first blood sample) suffered from an infectious, allergic, or inflammatory response. The subjects abstained from caffeine and nicotine for at least 8 hr before each session.
After an overnight fast, blood samples for the assays of IFN ␥ and IL-10 in culture supernatant were taken at 7:30 AM ( Ϯ 30 minutes). Effects of antidepressants on cytokine secretion were studied by stimulating whole blood with PHA and LPS and analyzing IFN ␥ and IL-10 production in culture supernatant . RPMI-1640 medium (Life Technologies, Belgium) with L-glutamine and phenol red and containing 10% of penicillin (Sigma) was employed with (stimulated) or without (unstimulated) 5 g/mL PHA (Murex, Belgium) ϩ 25 g/dL lipopolysaccharide (LPS; Sigma, Belgium). 1.8 mL of either one of these two media were placed into 24-well sterile plates, 0.2 mL of whole blood, 1/10 diluted, from each of the nine healthy volunteers was added. The antidepressants were dissolved in sterile water, whereas sterile water alone served as the corresponding control. 20 L of each antidepressant solution was added to the wells and gently mixed with the medium. Whole blood was seeded in the 24-well culture plates with clomipramine-HCl 10 Ϫ 6 and 10 Ϫ 9 M, sertraline-HCl 10 Ϫ 6 and 10 Ϫ 8 M, and trazodone-HCl 10 Ϫ 6 and 10 Ϫ 8 M. At this low antidepressant-vehicle concentrations and with this small volume of antidepressant solutions, no significant effects on the pH of the buffered whole blood culture may be expected. For each subject, 18 different wells were plated [i.e., 2 (with and without PHA ϩ LPS) ϫ 9 (three with RPMI-medium as control and six with two different concentrations of three different antidepressants)]. Samples were incubated for 72 h in a humidified atmosphere at 37 Њ C, 5% CO2. After incubation, the plates were centrifuged at 1500 rpm for 8 min. Supernatants were taken off carefully under sterile conditions, divided into eppendorf tubes, and frozen immediately at Ϫ 70 Њ C until thawed for assay of IFN ␥ and IL-10. The drug concentrations employed here were chosen on the basis of literature on the therapeutic plasma concentrations of these agents. Thus, the 10 Ϫ 6 M concentrations employed here are in the therapeutic range of plasma concentrations obtained during clinical treatment, whereas the lower concentrations correspond to subtherapeutical concentrations of the drugs. Nevertheless, the intracellular (e.g., T lymphocytes, monocytes) loading of these drugs in the in vivo condition in depressed patients treated with these drugs is difficult to estimate. Clomipramine, sertraline, and trazodone were kind gifts from CibaGeigy, Pfizer and Continental Pharma (Belgium), respectively.
IFN ␥ and IL-10 were quantified by means of ELISA methods (Eurogenetics, Tessenderlo, Belgium) based on appropriate and validated sets of monoclonal antibodies. In short, monoclonal antibodies specific for each component have been pre-coated onto 96-well microtiter plates (Eurogenetics Company, Transporstraat, Tessenderlo, Belgium). Standards and samples were pipetted into the wells and then incubated at 37 Њ C. Cytokines or receptor antagonists were bound by the immobilized antibody and incubated at 37 Њ C. After washing away any unbound substances, an enzyme-linked polyclonal antibody specific for each of these components was added to the wells and incubated at 37 Њ C. Following a wash to remove unbound antibody-enzyme reagents, a substrate solution was added to the wells for 10 min. Color development was stopped by sulfuric acid and the intensity of the color was measured by a microtiter plate reader (absorbance at 450 nm). All samples from the normal volunteers were assayed at the same time, in a single run with a single lot number of reagents and consumables employed by a single operator. The intraassay CV values for both analyses were less than 8%.
STATISTICS
Repeated measure design analyses of variance (RM ANOVAs) were used to examine the (1) within-subject variability with (a) the effect of PHA ϩ LPS treatment as temporal condition and (b) the effects of antidepressant drugs as temporal condition, that is, control (RPMI medium) and the three different drugs; control, 10 Ϫ 6 M versus lower concentrations; or control ϩ 6 conditions (two concentrations of the three drugs); and (2) betweensubject variability with gender as factor. Repeated measure design analyses of covariance (RM ANCOVAs) were used to examine the within-subject variability with drug treatment as temporal condition, PHA ϩ LPSinduced cytokine secretion as dependent variables and the unstimulated cytokine secretion as covariates. To examine the ratio of the secretion of pro-inflammatory (IFN ␥ ) versus negative immunoregulatory (IL-10) cytokines, the IFN ␥ /IL-10 ratio was computed as: z transformed IFN ␥ -z transformed IL-10. Relationships between variables were ascertained by means of Pearson's product moment correlation coefficients.
RESULTS
RM design ANOVAs with stimulation (PHA ϩ LPS stimulated versus unstimulated) and drugs (control versus the six drugs conditions) as within-subject factor and gender as between-subject factor showed significantly higher (F ϭ 173, df ϭ 1/92, p Ͻ 10 Ϫ 4 ) stimulated (mean ϭ 446 Ϯ 277 U/mL) than unstimulated (mean ϭ 43 Ϯ 150 U/mL) IFN ␥ concentrations and no significant stimulation ϫ drug (F ϭ .7, df ϭ 6/91, p ϭ .9), stimulation ϫ gender (F ϭ 1.7, df 1/91, p ϭ .2), stimulation ϫ drug ϫ gender (F ϭ .8, df ϭ 6/91, p ϭ .5) interactions, and no significant difference between men and women (F ϭ .6, df ϭ 1/7, p ϭ .5). RM design ANOVAs with the stimulation and drug conditions as within-subject and gender as between-subject factor showed a significantly higher (F ϭ 704, df ϭ 1/91, p Ͻ 10 Ϫ4 ) stimulated (mean ϭ 651 Ϯ 275 pg/mL) than unstimulated (mean ϭ 63 Ϯ 62 pg/mL) IL-10 secretion and no significant stimulation ϫ drug (F ϭ 1.1, df ϭ 6/91, p ϭ .4), stimulation ϫ gender (F ϭ 3.4, df ϭ 1/6, p Ͻ .06) and stimulation ϫ drug ϫ gender (F ϭ .6, df ϭ 6.91, p ϭ .7) interactions, and no significant difference between men and women (F ϭ .6, df ϭ 1/7, p ϭ .5). In the 27 control supernatants (three per subject), we found significant and positive correlations between the unstimulated and stimulated IL-10 (r ϭ .45, p ϭ .01, n ϭ 27), but not IFN␥ (r ϭ Ϫ.26, p ϭ .1, n ϭ 27), concentrations. Table 1 shows the effects of antidepressants on the unstimulated IFN␥ and IL-10 secretion and on the IFN␥/IL-10 ratio in 18 control supernatants and 3 ϫ 18 supernatants, which were incubated with clomipramine, sertraline, and trazodone (i.e., at the 10 Ϫ6 M and the lower concentrations). Thus, both low and higher concentrations of each of the antidepressants were combined and compared with the negative or positive con-trols. RM design ANOVAs with the drug condition as the within-subject factor, showed no significant differences in unstimulated supernatant IFN␥ and IL-10 and the IFN␥/IL-10 ratio between the control and antidepressant-incubated supernatants. RM ANOVAs, with the drug condition as within-subject factor, showed that (1) stimulated supernatant IFN␥ was significantly lower in supernatants incubated with the three antidepressants than in control supernatant; (2) stimulated supernatant IL-10 was significantly higher in supernatant incubated with clomipramine and sertraline than in control supernatant; and that (3) the stimulated IFN␥/ IL-10 ratio was significantly lower in supernatants incubated with clomipramine, sertraline, and trazodone than in control supernatant. RM ANCOVAs with the drug condition as within-subject factor, the stimulated cytokine values as dependent variables, and the unstimulated cytokine values as covariates did not change any of the above results: IFN␥ (F ϭ 4.5, df ϭ 3/60, p ϭ .007), IL-10 (F ϭ 3.0, df ϭ 3/60, p ϭ .03), and the IFN␥/IL-10 ratio (F ϭ 5.8, df ϭ 3/60, p ϭ .002). Table 2 shows the effects of the 10 Ϫ6 M concentration versus the lower concentrations of the three antidepressants on unstimulated and stimulated supernatant IFN␥ and IL-10. RM ANOVA with the drug condition as within-subject factor showed: (1) higher unstimulated supernatant IFN␥ in supernatants incubated with both concentrations of the antidepressants than in control supernatant; and (2) no significant differences either in unstimulated supernatant IL-10 or the IFN␥/ IL-10 ratio between the three conditions. RM ANOVA, with drug condition as within-subject factor, showed (1) significantly lower stimulated IFN␥ in supernatant incubated with the 10 Ϫ6 and lower antidepressant concentrations than in control supernatant; (2) significantly higher IL-10 in supernatant incubated with the 10 Ϫ6 concentrations of the antidepressants than in control supernatant; and (3) a significantly lower IFN␥/IL-10 ratio in supernatant incubated with both antidepressant concentrations. RM ANCOVAs with the drug condition as within-subject factor, the stimulated cytokine values as dependent variables, and the unstimulated cytokine values as covariates did not significantly change the above results: IFN␥ (F ϭ 7.8, df ϭ 2/70, p ϭ .001); IL-10 (F ϭ 4.5, df ϭ 2/70, p ϭ .01); and IFN␥/IL-10 ratio (F ϭ 13.5, df ϭ 2/70, p Ͻ 10 Ϫ4 ). Table 3 shows the effects of the three antidepressants at the two different concentrations on supernatant IFN␥ and IL-10 and the IFN␥/IL-10 ratio. RM ANOVA with drug condition (i.e., control and six antidepressant conditions) as the within-subject factor showed no significant differences in the unstimulated IFN␥, IL-10, or the IFN␥/IL-10 ratio between the seven conditions. RM ANOVAs, with drug condition as the within-subject factor, showed a significantly lower stimulated IFN␥/ IL-10 ratio in supernatant incubated with clomipramine 10 Ϫ6 M, sertraline 10 Ϫ6 and 10 Ϫ8 M, and trazodone 10 Ϫ6 M in control supernatant. RM ANCOVAs with the stimulated ratio as dependent variable and the unstimulated ratio as covariate did not change these results (F ϭ 3.2, df ϭ 6/48, p ϭ .009).
DISCUSSION
The main findings of this study are that clomipramine, sertraline, and trazodone have a significant suppressive effect on IFN␥ and a significant stimulatory effect on IL-10 secretion by whole blood stimulated with polyclonal activators. These in vitro effects were obtained at concentrations in the range of the therapeutic plasma concentrations achieved during clinical treatment with these antidepressants. The finding of the present study suggest that various antidepressive drugs, including SSRIs, tricyclic and heterocyclic antidepressants, may have negative immunoregulatory effects, because they significantly suppress the IFN␥/IL-10 ratio. These results extend those of Xia et al. (1996) , who found a trend toward a significant suppression of IFN␥ secretion by activated T cells preincubated with tricyclic antidepressants and SSRIs. Our findings that antidepressants have potent negative immunoregulatory effects corroborate the findings of Xia et al. (1996) , who found that tricyclics significantly inhibit IL-2 secretion by activated T lymphocytes and that tricyclics as well as SSRIs significantly blunt IL-1␤ and TNF␣ release by activated monocytes. However, while we studied cytokine release by LPS ϩ PHA-stimulated, diluted whole blood, Xia et al. (1996) examined cytokine release by separated T lymphocytes or monocytes. There is evidence that the in vivo release of cytokines is better reflected using the LPS ϩ PHAstimulated, diluted whole blood assay than using "washed" blood assays. Diluted whole blood stimulated with LPS ϩ PHA appears to be an appropriate and reproducible condition of culture to measure cytokine production, whereas isolated PBMC cultivated in media or whole blood stimulated with LPS or PHA (1) 5 (6) 8 (11) 8 (7) 64 (182) 84 (243) 49 (135) 83 (234) .2 6/48 .9 (2) 574 (208) 429 (228) 499 (265) 336 (213) 433 (298) 404 (352) 512 (323) 2.1 6/48
.07 IL-10 (pg/mL) (1) 56 (73) 59 (57) 60 (52) 75 (72) 62 (53) 75 (84) 55 (55) .5 6/48 .8 (2) 548 (257) 717 (261) 614 (196) 659 (270) 702 (249) 750 (437) 566 (218) yield a lower reproducibility . Comparing cytokine profiles by diluted whole blood with those of isolated PBMC, it was found that the variability in cytokine production by isolated PBMC is much larger than in diluted whole blood cultures . In diluted whole blood, the natural cell-to-cell interactions are preserved. The methods used to isolate PBMC modify the lymphocyte/monocyte ratio, that is, monocyte concentrations may be reduced during the separation process . A modified monocyte/lymphocyte ratio in isolated PMBC may influence the outcome of measurements of cytokine production. Because IL-10 is produced by, among others, monocytes, Th0, Th1, and Th2 cells (review: Katsikis et al. 1995) it appears to be important to measure IL-10 in cultures with a preserved monocyte/lymphocyte ratio. In diluted whole blood cultures circulating, endogenous immunoregulatory mediators, either pro-inflammatory or anti-inflammatory, are preserved, whereas isolation of PBMC may eliminate immunomodulatory agents . IFN␥ production is higher with LPS ϩ PHA than with LPS or PHA alone ). This may be explained by synergistic effects of PHA and LPS-induced IL-1 secretion on Th2 cells. Thus, diluted whole blood assays reflect the natural environment, while LPS ϩ PHA stimulation allows the functional characterization of the monocytic and T lymphocytic cytokines . Of course, this standardized method does not allow delineation of the precise contribution from each cell population to the cytokine production. Cultures on isolated or purified monocytes and T lymphocytes, as examined by Xia et al. (1996) , may assess the specific mechanisms involved, although this method does not reflect the in vivo situation. Nevertheless, the results of the present study and that of Xia et al. (1996) show that antidepressant drugs (i.e., tricyclics, heterocyclics and SSRIs) have negative immunoregulatory effects through suppression of monocytic and T lymphocytic pro-inflammatory cytokines and through stimulation of IL-10 secretion.
Another question is whether these ex vivo findings are relevant for the in vivo response of the immuneinflammatory system to antidepressants. Phrased differently, consideration of in vivo results is needed for a correct interpretation of ex vivo data. In this respect, it has been shown that subchronic treatment with fluoxetine, another SSRI, normalized the initially increased serum IL-6 concentrations in depressed patients (Sluzewska et al. 1995a (Sluzewska et al. , 1995b . In Wistar rats, an 8-week exposure to mild, unpredictable stress induces a depression-like state with an increased capacity of splenocytes to produce IL-1 and IL-2. The antidepressant effect of repeated administration of imipramine was accompanied by a reduction in IL-1 and IL-2 production (Kubera et al. 1996) . A single IP injection of 10 mg/kg desipramine to naive mice increases the capacity of splenocytes to produce IL-10 ( Kubera et al. 1998) . Subchronic treatment with tricyclic antidepressants and fluoxetine is able to suppress the acute phase response in major depression (Maes et al. 1997a) . SSRIs, such as sertraline and fluoxetine, attenuate the acute phase response in the olfactory bulbecomized and chronic mild stress model of depression in the rat Sluzewska et al. 1994) . Because an acute phase response in the above conditions is probably driven by hypersecretion of pro-inflammatory cytokines (Maes et al. 1993b ), these in vivo data are in accordance with the contention that antidepressants have negative immunoregulatory effects in vitro and in vivo. Not all studies, however, were able to find that short-term treatment with fluoxetine significantly suppressed initially increased serum IL-6 and IL-2R concentrations in major depression (Maes et al. 1995a) . Finally, it is generally believed that tricyclic antidepressants have immunosuppressive effects ex vivo as well as in vivo (review : Miller and Lackner 1989) .
As described in the beginning of this article, major depression is associated with an increased secretion of IFN␥ (Maes et al. 1994; Seidel et al. 1996a ) and increased secretion of neopterin, which production is induced by IFN␥ (Maes et al. 1994; Duch et al. 1984; Dunbar et al. 1992; Bonaccorso et al. 1997 ). In addition, psychological stress in humans significantly increases the stimulated production of pro-inflammatory cytokines, including IFN␥ (Maes et al. 1998a) . Humans with increased IFN␥ and decreased IL-10 secretion and, consequently, all increased IFN␥/IL-10 ratio, show significant stress-induced increments in depression and anxiety (Maes et al. 1998b ). Finally, administration of interferons, including IFN␥, results in behavioral effects and mood alterations, including symptoms reminiscent of depression and anxiety (Smith 1991; Gutterman et al. 1982; Weinberg et al. 1988) . Because antidepressants decrease the IFN␥/IL-10 ratio, it may be speculated that antidepressants exert some of their antidepressant effects through their negative immunoregulatory capacities.
The exact mechanisms by which antidepressive drugs exert their activity on the stimulated production of cytokines by whole blood is still unknown. These effects might be mediated by nonspecific mechanisms through inhibitory effects on lymphocyte blastogenesis, such as DNA synthesis in lymphocytes or alterations in second messenger cyclic AMP (Xia et al. 1996; Nahas et al. 1979) . The existence of receptors on immune cells for serotonergic neurotransmission provides another potential mechanism for the activity of antidepressants on the IRS. There is now some evidence that disorders in the central and peripheral metabolism of serotonin (5-HT) play a role in the pathophysiology of major depression and that antidepressant drugs exert their antidepressive effects through interactions with the serotonergic system (Maes and Meltzer 1995) . T lymphocytes constitutively express 5-HT receptors, such as 5-HT1A and 5-HT2A/2C receptors, as well as high affinity 5-HT transporter, whereas macrophages possess a specific active 5-HT uptake system similar in affinity to that of platelets (Aune et al. 1994; Jahnova 1994; Faraj et al. 1994; Jackson et al. 1988) . After stimulation with polyclonal activators or IFN␥, monocytes and T lymphocytes release 5-HT (review: Aune et al. 1994) . The uptake of [ 3 H]-5-HT by lymphocytes is potently inhibited by antidepressants such as clomipramine, fluoxetine, and fluvoxamine (Faraj et al. 1994) . It has been shown that 5-HT has some negative immunoregulatory effects as indicated by the following: 5-HT decreases mitogen-induced T lymphoproliferative responses; 5-HT suppresses lymphocyte DNA synthesis; 5-HT inhibits the migration of mononuclear leukocytes; 5-HT inhibits T-cell activation of normal spleen cells; 5-HT decreases IFN␥-induced major histocompatibility antigen class II expression on macrophages; and 5-HT decreases the synthesis of TNF␣ by macrophages (Sternberg et al. 1986; Bondesson et al. 1993; Bonnet et al. 1984; Kut et al. 1992) . Most importantly, zimelidine, an SSRI, and clomipramine reduce the number of IFN␥ secreting cells in mitogen stimulated cell cultures (Bengtsson et al. 1992 ). The receptors responsible for some of these effects were shown to be the 5-HT1 and 5-HT2A/C receptors (Idova and Cheido 1987; Jahnova 1994; Nordlind et al. 1992) . 5-HT1A antagonists and inhibitors of 5-HT synthesis may suppress IL-2-stimulated T cell proliferation and the production of Th1-like cytokines, including IFN␥ (Aune et al. 1994) . T lymphocytes depleted from their intracellular stores of 5-HT do not longer express the IL-2R after mitogenic stimulation (Young and Matthews 1995) . In summary, 5-HT, 5-HT1A, and 5-HT2A/ 2C receptor antagonists, SSRIs and depletion of intracellular 5-HT are all able to suppress various aspects of the IRS (Smejkal-Jagar and Boranic 1994). Thus, part of the immune effects of SSRI, tricyclic and heterocyclic antidepressants may be explained by their serotonergic activities, such as depletion of intracellular 5-HT stores, increased extracellular 5-HT, and/or 5-HT2A/2C receptor blockade.
There are now other preclinical data showing that antidepressants have a negative immunoregulatory activity and even that effects on cytokine production may play a role in the antidepressant activity of these drugs. First, chronic treatment with antidepressants significantly reduces substance P contents in the striatum, substantia nigra, and amygdala of the rat (Shirayama et al. 1996) . Because substance P may induce the production of pro-inflammatory cytokines in human monocytes (Lieb et al. 1996) , antidepressants could exert their immunosuppressive action, in part, through effects on substance P. Second, chronic treatment with imipramine induces IL-1 and IL-1R antagonist (IL1RA) mRNA in widespread area of rat brain (Suzuki et al. 1996) and induces a greater effect on IL-1RA mRNA than on IL-1 mRNA. The IL-1RA is a pure antagonist of the IL-1R and, as such, this endogenous molecule may inhibit the biological activities of IL-1 (Dinarello 1994; Dayer and Burger 1994) . Third, rolipram a novel antidepressant (Eckmann et al. 1988; Horowski and Sastre-y-Hernandez 1985) does not act on neurotransmitters systems directly, but it potently suppresses the production of pro-inflammatory cytokines, such as TNF␣ and IFN␥ (Sommer et al. 1995; Greten et al. 1995; Angel et al. 1995; Pettipher et al. 1996) . Fourth, there is some evidence that TNF␣ regulates the expression of adrenergic receptors, that TNF␣-induced regulation of noradrenaline release is associated with alterations of ␣2-adrenoceptor (␣2-AR) responsiveness and that chronic treatment with desipramine modulates ␣2-AR functions through an altered expression of TNF␣ (Ignatowski and Spengler 1994) .
